Synedica NAD+ & B12 Injection Pen is a dual-compound research formulation designed to support cellular energy metabolism, mitochondrial activity, and metabolic efficiency studies. This pen-based system combines nicotinamide adenine dinucleotide (NAD+) with vitamin B12 to deliver a synergistic approach for advanced laboratory research.
NAD+ plays a central role in cellular energy transfer and redox reactions, while vitamin B12 contributes to neurological and metabolic pathways. Together, these compounds are widely studied in longevity, energy optimisation, and cellular-performance research models.
Key Features
-
Combined NAD+ and B12 formulation
-
Pen-based delivery for controlled dosing
-
Designed for cellular and metabolic research
-
Consistent concentration and stability
-
Manufactured under laboratory-grade standards
How It Works
This formulation supports cellular metabolism by contributing to mitochondrial energy production and enzymatic activity. NAD+ functions as a key coenzyme in ATP generation, while B12 supports metabolic and neurological pathways involved in energy utilisation.
Research Applications
Synedica NAD+ & B12 Injection Pen Commonly selected for:
-
Cellular energy and mitochondrial research
-
Longevity and metabolic efficiency studies
-
Fatigue and energy-pathway investigations
-
Combination-compound research protocols
Pen-Based Delivery Advantage
The injection pen format improves handling consistency, reduces preparation variability, and supports repeatable dosing across extended research timelines.
Storage & Quality
Store refrigerated, protect from light, and do not freeze. Intended strictly for research use only.
Reviews
There are no reviews yet.